Inactive Instrument

News Stereotaxis Inc Nasdaq

Equities

US85916J4094

Real-time Estimate Cboe BZX Other stock markets 10:53:05 2024-04-24 am EDT			5-day change	1st Jan Change
2.5 ^USD	+82.48%		-2.84%	+71.25%

Mar. 04	Transcript : Stereotaxis, Inc., Q4 2023 Earnings Call, Mar 04, 2024
Mar. 04	Earnings Flash (STXS) STEREOTAXIS Reports Q4 Revenue $4.6M, vs. Street Est of $7.7M	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024	Apr. 22	AQ
Transcript : Stereotaxis, Inc., Q4 2023 Earnings Call, Mar 04, 2024	Mar. 04
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States	Mar. 04	AQ
Stereotaxis Reports 2023 Full Year Financial Results	Mar. 04	AQ
Earnings Flash (STXS) STEREOTAXIS Reports Q4 Revenue $4.6M, vs. Street Est of $7.7M	Mar. 04	MT
Stereotaxis, Inc. Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States	Mar. 04	CI
Stereotaxis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 04	CI
Stereotaxis, Inc. Provides Revenue Guidance for the First Quarter and Full Year 2024	Mar. 04	CI
North American Morning Briefing : Stock Futures -2-	Mar. 04	DJ
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology	Feb. 22	AQ
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024	Feb. 20	AQ
Roth MKM Starts Coverage on Stereotaxis with Buy Rating, $5 Price Target	Jan. 10	MT
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter	Jan. 08	AQ
Stereotaxis Announces First Patients Successfully Treated Using Magic Ablation Catheter	Jan. 08	CI
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients	Nov. 28	AQ
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference	Nov. 20	AQ
B. Riley Trims Stereotaxis' PT to $4 From $4.50 After Slight Q3 Miss, Maintains Buy Rating	Nov. 10	MT
Transcript : Stereotaxis, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Stereotaxis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Earnings Flash (STXS) STEREOTAXIS Posts Q3 Revenue $7.8M, vs. Street Est of $8.3M	Nov. 09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Stereotaxis Inc Nasdaq

Equities

US85916J4094

Summary

Filters